Michelle Brunnabend
Obstetrics & Gynecology · Oklahoma City, OKNPI 1992006886
Payments from drug & device makers
Across 172 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Mayne Pharma Commercial LLC$428
- Bayer$365
- Therapeuticsmd, Inc.$353
- Sage Therapeutics, LLC$159
- Evofem Biosciences, Inc.$111
- plus $825 from 21 others
What the payments were for
- Food & beverage$3,407100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $1,166 |
| Mayne Pharma Commercial LLC | 32 | $428 |
| Bayer | 18 | $365 |
| Therapeuticsmd, Inc. | 18 | $353 |
| Sage Therapeutics, LLC | 9 | $159 |
| Evofem Biosciences, Inc. | 7 | $111 |
| Agile Therapeutics, Inc. | 5 | $105 |
| Hologic Sales And Service, LLC | 7 | $89 |
| Applied Medical Resources Corporation | 1 | $83 |
| Exeltis, USA Inc. | 4 | $61 |
| Organon | 4 | $59 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Pfizer | 3 | $56 |
| Millicent US Inc | 2 | $37 |
| Avion Pharmaceuticals | 2 | $33 |
| Exact Sciences | 2 | $33 |
| Astellas Pharma US Inc | 1 | $32 |
| Dexcom, Inc. | 1 | $24 |
| Medline Industries LP | 1 | $22 |
| Meditrina | 1 | $21 |
| Merck | 1 | $19 |
| Alydia Health | 1 | $18 |
| Medtronic | 1 | $17 |
| Coopersurgical, Inc. | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$443
- IMVEXXY$122
- NEXTSTELLIS$119
How this compares
$3,407 in reported general payments places this provider in the 70th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 17 | $4,503 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $56 | $4,50317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 396 obstetrics & gynecology providers in Oklahoma.
Other obstetrics & gynecology in Oklahoma City
- Kathleen MooreOklahoma City$11.1M
- Tori OdanielOklahoma City$917K
- Beverly VavrickaOklahoma City$22K
- Monica ReidOklahoma City$20K
- Hoda MaaroufOklahoma City$15K
- Misty WaymanOklahoma City$13K
- Catherine HildebrandOklahoma City$12K
- Catherine GardnerOklahoma City$12K
- Kamal ShanbourOklahoma City$10K
- Darren GoffOklahoma City$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.